Eli Lilly weight loss injection drug also helps with obstructive sleep apnea, company says

A closeup of a beam scale is seen in New York on April 3, 2018. The Eli Lilly weight loss injection Zepbound reduced the intensity of obstructive sleep apnea in patients by nearly two-thirds, the pharmaceutical giant announced on Wednesday, …weight loss injection Zepbound reduced the intensity of obstructive sleep apnea in patients by nearly two-thirds, the pharmaceutical giant announced Wednesday.

Obstructive sleep apnea involves the restriction of airflow, and obese people are more likely to suffer from it, according to the Centers for Disease Control and Prevention. It impacts 80 million U.S. adults, with more than 20 million suffering from moderate to severe obstructive sleep apnea, the company said.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Eli Lilly’s weight loss drug Zepbound found to reduce sleep apnea, company saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
출처: NBCNewsHealth - 🏆 707. / 51 더 많은 것을 읽으십시오 »

Stocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and moreThese are the stocks posting the largest moves in the premarket.
출처: CNBC - 🏆 12. / 72 더 많은 것을 읽으십시오 »